An analytical perspective of NMR spectroscopy of biological fluids and cells

Annals of Clinical Biochemistry

Volumn 33, Issue 4, 1996, Pages 290-307

  Reglinski, John ^a   Watson, Ian D ^a  

^a NONE

Author keywords

Clinical analysis; Clinical biochemistry; High field NMR spectroscopy; In vitro analysis

Indexed keywords

ACCURACY; ANALYTIC METHOD; BIOCHEMISTRY; BODY FLUID; CALIBRATION; CYTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUALITY CONTROL; SAFETY; SHORT SURVEY;

EID: 0029884799     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300404     Document Type: Short Survey

References (86)

1. 1H Magnetic resonance absorption and water content of biological materials. Phys Rev 1952; 85: 708-10
2. 2O exchange experiments. Arch Biochem Biophys 1956; 63: 221-5
3. Lauterbaur PC. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 1973; 242: 190-1
4. Bock JL. Nuclear magnetic resonance in the clinical laboratory. Am J Clin Pathol 1989; 91 (suppl): S19-26
5. Szwegold BS. NMR spectroscopy of cells. Ann Rev Physiol 1992; 54: 775-98
6. Decertaines JD, Henriksen O, Spisni A, Cortsen M, Ring PB. Tissue characterisation by magnetic resonance spectroscopy and imaging - results of a concerted research project on the European Economic Community. 4. In vivo measurements of proton relaxation times in human brain, liver and skeletal muscle. A multicentre MRI study. Magn Reson Imag 1993; 11: 841-50
7. Henriksen O, Decertaines JD, Spisni A, Cortsen M, Ring PB. Tissue characterisation by magnetic resonance spectroscopy and imaging - results of a concerted research project on the European Economic Community. 5. In vivo field dependence of proton relaxation times in human brain, liver and skeletal muscle. A multicentre MRI study. Magn Reson Imag 1993; 11: 851 6
8. Shulman RG, Blamire AM, Rothman DL, McCarthy G. Nuclear magnetic resonance imaging and spectroscopy of human brain function. Proc Natl Acad Sci USA 1993; 90: 3127-33
9. Homans SW. A Dictionary of Concepts in NMR. Oxford: Oxford Science Publications, Clarendon Press, 1992
10. Hore PJ. Nuclear Magnetic Resonance. Oxford: Oxford University Press, 1995
11. Kemp W. NMR in Chemistry - A Multinuclear Introduction. London: Macmillan Press Ltd, 1986
12. Saunders JKM, Hunter BK. Modern NMR Spectroscopy - A Guide for Chemists. Oxford: Oxford University Press, 1993
13. Harris RK. NMR Spectroscopy - A Physiochemical View. London: Longman Scientific & Technical, 1986
14. Shaw D. Fourier Transform N.M.R. Spectroscopy: Studies in Physical and Theoretical Chemistry, 2nd edn. Amsterdam: Elsevier Science Publishers, 1987: 30
15. Derome AE. Modern NMR Techniques for Chemistry Research: Tetrahedron Organic Chemistry Series, Vol 6. Oxford: Pergamon Press, 1991
16. Gartland KPR, Bonner FW, Nicholson JK. Biochemical characterisation of para-aminophenol induced nephrotoxic lesions in the F344 rat. Arch Toxicol 1989; 63: 97-106
17. 1H-NMR Spectroscopy. J Pharm Biomed Anal 1990; 8: 939-44
18. Brindle KM, Campbell ID, Simpson RJ. NMR Methods for Studying Enzyme Kinetics in Cells and Tissues [Review]. In: Berliner LJ, Reuben J, eds. Biological Magnetic Resonance, Vol 7. New York: Plenum Press, 1987: 81-129
19. McKee RF, Reglinski J, Smith WE, Carter DC. The detection of malignancy by proton nuclear magnetic resonance Spectroscopy of plasma: a re-appraisal. Surg Res Commun 1989; 6: 131-6
20. 1H-NMR analysis of amniotic fluid. J Pharm Biomed Anal 1993; 11: 629-32
21. 1H spin echo NMR. Clin Chim Acta 1991; 201: 45-58
22. Sadler PJ. Proton NMR studies of urine. In: McBrien DCH, Slater TF, eds. Biochemical Mechanisms of Platinum Antitumor Drugs. Oxford: IRL Press Ltd, 1986: 383-92
23. Wilson ID, Nicholson JK. Solid phase extraction chromatography and NMR Spectroscopy (SPECNMR) for the rapid identification of drug metabolites in urine. J Pharm Biomed Anal 1988; 6: 151-65
24. 1H nuclear magnetic resonance spectrometry. Anal Chem 1985; 57: 2294-9
25. 87Rb nuclear magnetic resonance Spectroscopy; implications for the measurement of cation transport activity in vivo. Clin Sci 1990; 78: 303-9
26. Smith RC, McCarthy S. Physics of magnetic resonance. J Reproduct Med 1992; 37: 19-26
27. 1H NMR shifts in biomedical samples using external calibration systems. Arkiv Kemi 1966; 25: 377-93
28. Chapman D, Kamat VB, De Ger J, Penkett SA. NMR of erythrocyte membrane. Nature 1968; 213: 74-5
29. Dean JA. Use of NMR in determining molecular structure of urinary constituents of low molecular weight. Clin Chem 1968; 14: 326-38
30. Chapman D, Leslie RB, Hirz R, Scanu A. 220 MHz NMR of high density serum lipoprotein. Nature 1969; 221: 260-1
31. 31P NMR: applications to human serum high density lipoprotein. Biochim Biophys Acta 1974; 348: 155-60
32. 31H magnetic resonance. J Biol Chem 1973; 248: 7276-8
33. Damadian R. Tumour detection by nuclear magnetic resonance. Science 1971; 171: 1151-7
34. 2O solution in NMR in the life sciences. In: Bradbury EM, Nicolini C, eds. NATO ASI Series A: Life Sciences Vol 107. New York: Plenum Press, 1986: 1-10
35. 2O signal in proton FT/NMR spectroscopy [Review]. In: Berliner LJ, Reuben J, eds. Biological Magnetic Resonance, Vol 9. New York: Plenum Press, 1990: 199-240
36. Fantini J, Galons JP, Marvaldi J, Canioni PJ. Growth of a human colonic adenocarcinoma cell line (HT 29) on microcarrier beads; metabolic studies by 31 phosphorus nuclear magnetic resonance spectroscopy. Int J Cancer 1987; 39: 255-60
37. 31P NMR measurements of intracellular pH and 2,3-diphosphoglycerate in erythrocytes. Scand J Clin Lab Invest 1987; 47: 233-7
38. Elgavish GA. NMR spectroscopy of the intact heart. In: Berliner LJ, Reuben J, eds. A Review of Biological Magnetic Resonance, Vol 7. New York: Plenum Press, 1987: 1-80
39. Bottomley PA, Cousins JP, Pendrey DL, Wagle WA, Hardy CJ, Eames FA, et al. Alzheimer's dementia - quantification of energy metabolism and mobile phosphoester with 31-P NMR spectroscopy. Radiology 1992; 183: 695-9
40. Rajanayagam V, Lee, RR, Ackerman Z, Bradley WG, Ross BD. Quantitative 31-P MR spectroscopy of the liver in alcoholic cirrhosis. J Magn Res Imag 1992; 2: 183-90
41. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neur Sci 1993; 16: 201-6
42. 13C Nuclear magnetic resonance spectroscopy of glucose metabolism in human red blood cells. Magn Reson Med 1988; 8: 340-4
43. 13C nuclear magnetic resonance spectroscopy. FEBS Lett 1989; 247: 86-90
44. Shulman GI, Rothman DL, Jue T, Stein P, Defronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by C-13 nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223-8
45. 23Na NMR measurement of maximal rate of active sodium efflux from human red blood cells. Magn Reson Med 1989; 9: 262-72
46. 23Na NMR. Magn Res Med 1989; 9: 262-72
47. Levy LA, Murphy E, London RE. Synthesis and characterisation of 19-F NMR chelators for the measurement of cytosolic free calcium. Am J Physiol 1987; 252 (4pt 1): C441-9
48. 1H NMR urinalysis. Clin Chim Acta 1993; 214: 165-73
49. Ghauri FY, Blackledge CA, Glen RC, Sweatman BC, Linden JC, Beddell CR, et al. Quantitative structure metabolism relationship for substituted benzoic acids in rats. Computational chemistry, NMR spectroscopy and pattern recognition studies. Biochem Pharm 1992; 44: 1935-36
50. Bell JD, Lee JA, Lee HA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991; 1096: 101-7
51. 1H NMR studies of reactions of copper complexes with human blood plasma and urine. Biochem Pharm 1992; 43: 1137-45
52. 1H NMR studies of human plasma; assignment of resonances for lipoproteins. FEBS Lett 1987; 219: 239-43
53. Sims CJ, Fujito DT, Durholt DR, Dakok J, Giles HR, Wilkinson DA. Quantitation of human amniotic fluid constituents by high resolution proton nuclear magnetic resonance (NMR) spectroscopy. Prenatal Diag 1993; 13: 473-80
54. Ellul JPM, Murphy GM, Parkes HG, Slapa RZ, Dowling RH. Nuclear magnetic resonance spectroscopy to determine the micellar cholesterol in human bile. FEBS Lett 1992; 300: 30-2
55. Hiraoka A, Minra I, Hattori M, Tominaga I, Kushida K, Maeda M. Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis. Biol Pharm Bull 1994; 1: 1-4
56. 1H-NMR spectroscopy of human cerebrospinal fluid effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal 1993; 11: 651-64
57. 1H Nuclear magnetic resonance studies of human synovial fluid in arthritic disease states as an aid to confirming metabolic activity in the synovial cavity. Clin Sci 1993; 85: 343-51
58. 1H Nuclear magnetic resonance investigation of synovial fluid components in osteoarthritis, rheumatoid arthritis and traumatic effusion. Br J Rheumatol 1989; 28: 23-7
59. Fossel ET, Carr JM, McDonagh J. Detection of malignant tumours: water suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 1986; 315: 1369-75
60. Replies to Ref 59 from various groups. N Engl J Med 1986; 316: 1411-15
61. Kriat M, Vion-Dury J, Confort-Gouny S, Faure R, Viout P, Sciaky M, Sari H, Cozzonne PJ. Analysis of plasma lipids by NMR spectroscopy: application to modification induced by malignant tumours. J Lipid Res 1993; 34: 1009-19
62. Verdery RB, Benham DF, McLennan I, Busby MJ, Wehrle JP, Glickson JD. P NMR resonance methyl and methylene linewidths for plasma decrease during postprandial lipemia. Biochim Biophys Acta 1989; 1006: 287-90
63. Herring FG, Phillips PS, Pritchard PH. Proton magnetic resonance spectroscopy of plasma from patients with dyslipoproteinemia - identification of factors governing methyl and methylene line widths. J Lipid Res 1989; 30: 521-8
64. Smith ICP, Smart CR, Feller W, Bunnag W, Miya F, Hughes P., et al. A clinical trial on the use of magnetic resonance spectroscopy of plasma for detection of cancer. Cancer J 1991; 4: 125-30
65. Lind T. In: Lestner C ed. Amniotic Fluid Geigy Scientific Tables. New York: C Geigy, 1981: 197-212
66. Campbell ID, Brown FF. NMR studies of red cells. Phil Trans R Soc Lon 1980; B289: 395-406
67. 1H NMR methods for the non-invasive study of metabolism and other processes involving small molecules in intact erythrocytes. J Biochem Biophys Meth 1984; 9: 277-304
68. 1H spin echo NMR II: oxidation of intracellular glutathione as a consequence of penicillamine therapy. J Med Chem 1992; 35: 2134-7
69. Reglinski J, Smith WE, Wilson R, Buchanan LM, McKillop JH, Thomson JA. Spin echo NMR studies on intact erythrocytes: changes in cellular metabolism as a consequence of carbimazole therapy. Clin Endocrinol 1992; 37: 319-24
70. Garner M, Reglinski J, Smith WE, McMurray J. The oxidation state of glutathione in the erythrocyte. Clin Science 1992; 83: 637
71. 1H spin echo NMR spectroscopy of intact erythrocytes. J Mol Cell Cordiol 1990; 22 (suppl II): S99
72. Russel P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance and human thyroid neoplasm 1. Discrimination between benign and malignant neoplasma. Am J Med 1994; 96: 383-8
73. Lean CL, Newland RC, Ende DA, Bokey EL, Smith ICP, Mountford CE. Assessment of human colorectal biopsies by H-1 MRS - correlation with histopathology. Magn Reson Med 1993; 30: 525-33
74. 1H NMR applications to the study of leukemic lymphocytes. Br J Cancer 1980; 41: 1000-3
75. Agris PF, Campbell ID. Proton NMR of intact friend leukemia cells: phosphorylcholine increase during differentiation. Science 1982; 216: 1325-7
76. 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Br J Cancer 1991; 63: 953-8
77. 31P NMR spectra of human breast tumours. Variation in phospholipid metabolism. Br J Cancer 1991; 63: 514-16
78. 31P magnetic resonance spectroscopy of human colon cancer. Cancer Res 1990; 50: 527-32
79. Su B, Kappler F, Szwergold BS, Brown TR. Identification of a putative tumour marker in breast and colon cancer. Cancer Res 1990; 53: 1751-4
80. Lyon RC, Cohen JS, Faustino PJ, Megnin F, Myers CE. Glucose metabolism in drug sensitive and drug resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res 1988; 48: 870-7
81. Lean CL, Mackinnon WB, Delikatny EJ, Whitehead RH, Mountford CE. Cell surface fucosylation and magnetic resonance spectroscopy characterisation of human malignant colorectal cells. Biochemistry 1992; 31: 11095-105
82. Delikatny EJ, Russel P, Hunter JC, Hancock R, Atkinson KH, Vanahaaftenday C, et al. Proton MR and human cervical neoplasia - Ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other pre-invasive lesions. Radiology 1993; 188: 791-6
83. 1H nuclear magnetic resonance spectra by the application of chemometric techniques [Annual Meeting]. Proc Soc Magn Reson Med 1992; 11: 161
84. Reglinski J, Smith WE, Suckling CJ, Stewart MJ, Watson ID, Al-Kabban M. Doxorubicin induced altered glycolytic patterns in the leukemic cell studied by proton spin echo NMR. Clim Chim Acta 1988; 175: 285-90
85. Reglinski J, Smith WE, Al-Kabban M, Stewart MJ, Watson ID. A cellular based, NMR compatible model for solid tumour. J Pharm Biomed Anal 1990; 8: 721-4
86. 1H spin echo NMR and HPLC to confirm doxorubicin induced depletion of glutathione in the HeLa cell. Br J Cancer 1988; 57: 553-8